Lights and shadows in cardiac regeneration

Given that the adult human heart has an extremely limited regenerative capacity, diseases characterized by contractile cell loss, as myocardial infarction and cardiomyopathies, lead to ventricular remodeling and heart failure. Hence, diverse strategies to promote myocardial regeneration have been pr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Giménez, Carlos Sebastián, Crottogini, Alberto José
Formato: Articulo Revision
Lenguaje:Inglés
Publicado: 2019
Materias:
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/126790
https://pmr.safisiol.org.ar/archive/id/108
Aporte de:
Descripción
Sumario:Given that the adult human heart has an extremely limited regenerative capacity, diseases characterized by contractile cell loss, as myocardial infarction and cardiomyopathies, lead to ventricular remodeling and heart failure. Hence, diverse strategies to promote myocardial regeneration have been proposed and assessed in animals and humans with ischemic heart disease. Of these, gene transfer and especially stem cell therapy have been used. So far, the overall main outcome is a gross disparity between the promising results obtained in mammalian models and the poor, if any, benefit observed in randomized, controlled clinical trials. Many reasons may account for this disappointing scenario. Some, including flawed trial design and methodology, differences in cell type and dosing as well as in route of administration, erroneous end points selection and heterogeneous patient populations have been extensively discussed in comprehensive reviews. Others, more recently addressed, signal the use of inadequate or non-precise laboratory techniques in cell identification and fate, this leading to precarious or misleading conclusions. We hereby summarize part of the work done and quote some new approaches, like the use of induced pluripotent stem cells and the promotion of selfregeneration by targeting the adult cardiomyocyte cell cycle, that may cast some light in the otherwise shadowy field of cardiac regeneration.